Recent interest has emerged on 5F-ADB, a synthetic opioid falling under the broader category of designer compounds. Limited data currently exists regarding its exact pharmacological actions, however initial reports suggest it acts as a potent agonist at 5-HT receptors, likely causing outcomes similar to those of established copyright medications. R